News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Genetic Technologies Limited (GTG.AX) Release: the Centers for Women's Health in Stamford CT Pioneers Breast Cancer Risk Assessment


3/18/2013 12:36:53 PM

STAMFORD, Conn., March 18, 2013 (GLOBE NEWSWIRE) -- Dr. Joel Evans, Founder and Director of The Center for Women's Health, is one of the first physicians in the nation to make the BREVAGen™ predictive risk test available to his patients. Clinically validated, BREVAGen is the latest advance in assessing a woman's unique risk of developing non-familial or sporadic breast cancer.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES